Kezar Life Sciences, Inc. 8-K

What Happened

• Kezar Life Sciences (KZR) filed an 8‑K reporting separation agreements dated April 1, 2026, with CEO Christopher J. Kirk, Ph.D., CFO/Secretary Marc L. Belsky and COO Mark Schiller. Each officer’s employment will terminate at the Effective Time defined in those agreements, and severance benefits are provided (subject to release of claims).
• On April 1, 2026, Kezar also entered a Lease Termination Agreement with GNS South Tower, LP to end its lease for ~48,714 rentable sq. ft. at 4000 Shoreline Court, San Francisco early (original lease expiration was July 31, 2026), effective April 1, 2026. The company agreed to approximately $2.0 million in consideration (see Key Details).
• The filing reiterates the previously announced merger agreement with Aurinia (Merger Sub expected to merge into Kezar); the proposed transaction contemplates $6.955 per share in cash plus one contingent value right (CVR) per share. The buyer’s formal Offer has not yet commenced.

Key Details

• Lease termination: ~$2.0 million total consideration — ~$1.3 million paid at signing and surrender of ~ $0.7 million security deposit to the landlord. Space: ~48,714 rentable sq. ft.; address: 4000 Shoreline Court, San Francisco. Original lease exp. July 31, 2026; terminated effective April 1, 2026.
• Executive separations: Separation Agreements dated April 1, 2026. Dr. Kirk will receive his defined Severance Payment in a lump sum (less required withholdings); Mr. Belsky and Mr. Schiller get a one‑time cash payment equal to 12 months of health insurance premium costs at termination. Severance is contingent on each officer signing a general release of claims.
• The company stated there were no disagreements between the officers and Kezar. Exhibits (Leases and Separation Agreements) are filed with the 8‑K.
• Merger context: previously filed Merger Agreement with Aurinia — proposed consideration is $6.955 cash per share plus one CVR; Offer materials will be filed and distributed when the tender offer commences.

Why It Matters

• Leadership change: the planned departure of the CEO, CFO and COO is a material governance event that could affect operations, strategy and investor confidence until successors or transition plans are disclosed.
• Cash impact and facility changes: the ~$2.0M payment and surrender of the deposit are near‑term, known cash outflows and reflect the company exiting a large leased facility months before the original lease end—this may affect future occupancy costs and operating footprint.
• Merger timing and payoffs: separations and the lease termination occur in the context of the pending Aurinia transaction; severance terms reference change‑in‑control protections. Shareholders should watch for the buyer’s Offer materials and the Company’s Schedule 14D‑9 for further details before making decisions.